Latest Breaking News On - Safety profile from efgartigimod clinical trials - Page 1 : vimarsana.com

argenx SE: argenx Highlights Data Evaluating VYVGART in Neuromuscular Autoimmune Disease at AANEM and MGFA Scientific Sessions

argenx SE: argenx Highlights Data Evaluating VYVGART in Neuromuscular Autoimmune Disease at AANEM and MGFA Scientific Sessions
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNoord hollandMjamesf howardGil wolfeDemyelinating polyneuropathyYuebing liA gordon smithPushpa narayanaswamiGlenn phillipsCynthia qiLuc truyenTom hughesBen petokJamesf howard jrAntoine azar

Argenx Highlights Data Evaluating VYVGART in Neuromuscular Autoimmune Disease at AANEM and MGFA Scientific Sessions

Long-term clinical trial and real-world data illustrate VYVGART® drives consistent, repeatable and clinically meaningful responses, including minimal symptom expression in generalized myasthenia.

United kingdomNoord hollandUnited statesDemyelinating polyneuropathyTom hughesA gordon smithYuebing liGil wolfeRichard lewisBen petokLuc truyenJamesf howard jrGlenn phillipsTuan vuPushpa narayanaswamiKelly gwathmey

argenx Highlights Data Evaluating VYVGART in Neuromuscular Autoimmune Disease at AANEM and MGFA Scientific Sessions

Long-term clinical trial and real-world data illustrate VYVGART® drives consistent, repeatable and clinically meaningful responses, including mini.

Noord hollandUnited statesUnited kingdomPushpa narayanaswamiCynthia qiJamesf howard jrRichard lewisMjamesf howardLuc truyenGil wolfeTuan vuBen petokAntoine azarTom hughesYuebing liA gordon smith